These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1090 related articles for article (PubMed ID: 8497849)
1. Distribution of tissue factor pathway inhibitor in normal and malignant human tissues. Werling RW; Zacharski LR; Kisiel W; Bajaj SP; Memoli VA; Rousseau SM Thromb Haemost; 1993 Apr; 69(4):366-9. PubMed ID: 8497849 [TBL] [Abstract][Full Text] [Related]
2. Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding. Zacharski LR; Memoli VA; Morain WD; Schlaeppi JM; Rousseau SM Thromb Haemost; 1995 May; 73(5):793-7. PubMed ID: 7482405 [TBL] [Abstract][Full Text] [Related]
3. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the ISTH. Osterud B; Bajaj MS; Bajaj SP Thromb Haemost; 1995 May; 73(5):873-5. PubMed ID: 7482419 [TBL] [Abstract][Full Text] [Related]
4. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162 [TBL] [Abstract][Full Text] [Related]
5. Cellular localization of activated factor X by Xa-specific probes. Zacharski LR; Dunwiddie C; Nutt EM; Hunt J; Memoli VA Thromb Haemost; 1991 May; 65(5):545-8. PubMed ID: 1871716 [TBL] [Abstract][Full Text] [Related]
6. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor. Iakhiaev A; Ruf W; Rao LV Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues. Bajaj MS; Kuppuswamy MN; Manepalli AN; Bajaj SP Thromb Haemost; 1999 Sep; 82(3):1047-52. PubMed ID: 10494762 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation. Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212 [TBL] [Abstract][Full Text] [Related]
9. Tissue factor pathway inhibitor (TFPI). Rucińska M; Gacko M; Skrzydlewski Z Rocz Akad Med Bialymst; 1997; 42 Suppl 1():118-22. PubMed ID: 9337530 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue. Wojtukiewicz MZ; Sierko E; Zimnoch L; Kozlowski L; Kisiel W Thromb Haemost; 2003 Jul; 90(1):140-6. PubMed ID: 12876637 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIa. Valentin S; Reutlingsperger CP; Nordfang O; Lindhout T Thromb Haemost; 1995 Dec; 74(6):1478-85. PubMed ID: 8772224 [TBL] [Abstract][Full Text] [Related]
13. Expression of tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinoma. Wojtukiewicz MZ; Zacharski LR; Ruciñska M; Zimnoch L; Jaromin J; Rózañska-Kudelska M; Kisiel W; Kudryk BJ Thromb Haemost; 1999 Dec; 82(6):1659-62. PubMed ID: 10613652 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor. Lindhout T; Franssen J; Willems G Thromb Haemost; 1995 Sep; 74(3):910-5. PubMed ID: 8571320 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184 [TBL] [Abstract][Full Text] [Related]
16. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor. Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842 [TBL] [Abstract][Full Text] [Related]
17. Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI). Chang JY; Monroe DM; Oliver JA; Liles DK; Roberts HR Thromb Haemost; 1998 Feb; 79(2):306-9. PubMed ID: 9493581 [TBL] [Abstract][Full Text] [Related]
18. Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts. Udagawa K; Yasumitsu H; Esaki M; Sawada H; Nagashima Y; Aoki I; Jin M; Miyagi E; Nakazawa T; Hirahara F; Miyazaki K; Miyagi Y Placenta; 2002; 23(2-3):145-53. PubMed ID: 11945080 [TBL] [Abstract][Full Text] [Related]
19. Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity. Salemink I; Franssen J; Willems GM; Hemker HC; Li A; Wun TC; Lindhout T Thromb Haemost; 1998 Aug; 80(2):273-80. PubMed ID: 9716152 [TBL] [Abstract][Full Text] [Related]
20. Localization of blood coagulation factors in situ in pancreatic carcinoma. Wojtukiewicz MZ; Rucinska M; Zacharski LR; Kozlowski L; Zimnoch L; Piotrowski Z; Kudryk BJ; Kisiel W Thromb Haemost; 2001 Dec; 86(6):1416-20. PubMed ID: 11776308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]